South Korea New-Born Screening Market was valued at USD 0.1 Billion in 2022 and is projected to reach USD 0.25 Billion by 2030, growing at a CAGR of 10.0% from 2024 to 2030.
The South Korea New-Born Screening Market is growing rapidly, driven by advancements in technology and a greater emphasis on early detection of congenital disorders. Newborn screening (NBS) is essential for identifying metabolic, genetic, and other conditions in infants that may otherwise go unnoticed until they become more severe. The South Korean healthcare system has been expanding its NBS capabilities, integrating cutting-edge diagnostic tools to improve patient outcomes and reduce long-term healthcare costs.
South Korea’s government mandates screening for several diseases at birth, such as phenylketonuria (PKU), congenital hypothyroidism, and other metabolic disorders. As the demand for more accurate and faster testing grows, the industry is responding with innovations in testing methodologies, including next-generation sequencing (NGS) and tandem mass spectrometry. These advancements not only provide quicker and more reliable results but also allow for the detection of a broader range of diseases. With a population that values healthcare and well-being, South Korea is poised to lead the market in Asia, setting trends for early medical interventions.
Key players in the South Korean newborn screening market are focusing on expanding their product portfolios to meet the increasing needs of the healthcare sector. These companies are working closely with government agencies to ensure the widespread availability of screening tests across hospitals, clinics, and healthcare institutions. There is also a rise in demand for automation and AI-driven solutions to streamline screening processes, improve test accuracy, and reduce human error.
Industries related to healthcare, technology, and pharmaceuticals are heavily investing in this market. The growing recognition of the importance of early diagnosis is encouraging public-private partnerships, which are accelerating the development of new screening technologies. For example, the integration of machine learning algorithms in diagnostic tools can enhance predictive capabilities, allowing healthcare providers to identify potential health risks at an early stage, ultimately leading to better patient outcomes.
With the increasing awareness of genetic disorders and the advantages of early intervention, South Korea’s newborn screening market is expected to continue its rapid expansion. This growth is fueled by a combination of technological advancements, government initiatives, and an increasing demand for high-quality healthcare. As the market evolves, stakeholders from various industries must work collaboratively to meet the growing requirements and demands of this crucial healthcare segment.
Get an In-Depth Research Analysis of the South Korea New-Born Screening Market Size And Forecast [2025-2032]
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Covidien
Masimo
Waters
Natus Medical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea New-Born Screening Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea New-Born Screening Market
Blood Spot Screening
Hearing Screening
Critical Congenital Heart Disease (CCHD) Screening
Metabolic Screening
Standard Newborn Screening
Extended Newborn Screening
Point-of-Care Testing
Post-Natal Screening
Screening Kits
Assay Instruments
Reagents and Consumables
Software and Data Management Systems
Hospitals
Diagnostic Laboratories
Pediatric Clinics
Research Institutions
Mass Spectrometry
Genetic Testing Technologies
Immunoassays
Polymerase Chain Reaction (PCR)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea New-Born Screening Market Research Analysis
1. Introduction of the South Korea New-Born Screening Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea New-Born Screening Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea New-Born Screening Market, By Type
6. South Korea New-Born Screening Market, By Application
7. South Korea New-Born Screening Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea New-Born Screening Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/